Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Differential Expression of the Activator Protein 1 Transcription Factor Regulates Interleukin-1ß Induction of Interleukin 6 in the Developing Enterocyte.

Cahill CM, Zhu W, Oziolor E, Yang YJ, Tam B, Rajanala S, Rogers JT, Walker WA.

PLoS One. 2016 Jan 22;11(1):e0145184. doi: 10.1371/journal.pone.0145184. eCollection 2016.

2.

Global Analysis of Mouse Polyomavirus Infection Reveals Dynamic Regulation of Viral and Host Gene Expression and Promiscuous Viral RNA Editing.

Garren SB, Kondaveeti Y, Duff MO, Carmichael GG.

PLoS Pathog. 2015 Sep 25;11(9):e1005166. doi: 10.1371/journal.ppat.1005166. eCollection 2015 Sep.

3.

Aaptamines from the marine sponge Aaptos sp. display anticancer activities in human cancer cell lines and modulate AP-1-, NF-κB-, and p53-dependent transcriptional activity in mouse JB6 Cl41 cells.

Dyshlovoy SA, Fedorov SN, Shubina LK, Kuzmich AS, Bokemeyer C, Keller-von Amsberg G, Honecker F.

Biomed Res Int. 2014;2014:469309. doi: 10.1155/2014/469309. Epub 2014 Jul 23.

4.

Cleavage of the JunB transcription factor by caspases generates a carboxyl-terminal fragment that inhibits activator protein-1 transcriptional activity.

Lee JK, Pearson JD, Maser BE, Ingham RJ.

J Biol Chem. 2013 Jul 26;288(30):21482-95. doi: 10.1074/jbc.M113.485672. Epub 2013 Jun 9.

5.

Phosphoproteome dynamics reveal novel ERK1/2 MAP kinase substrates with broad spectrum of functions.

Courcelles M, Frémin C, Voisin L, Lemieux S, Meloche S, Thibault P.

Mol Syst Biol. 2013 May 28;9:669. doi: 10.1038/msb.2013.25.

6.

Epstein-Barr virus Zta upregulates matrix metalloproteinases 3 and 9 that synergistically promote cell invasion in vitro.

Lan YY, Yeh TH, Lin WH, Wu SY, Lai HC, Chang FH, Takada K, Chang Y.

PLoS One. 2013;8(2):e56121. doi: 10.1371/journal.pone.0056121. Epub 2013 Feb 7.

7.

PAX2 protein induces expression of cyclin D1 through activating AP-1 protein and promotes proliferation of colon cancer cells.

Zhang HS, Yan B, Li XB, Fan L, Zhang YF, Wu GH, Li M, Fang J.

J Biol Chem. 2012 Dec 28;287(53):44164-72. doi: 10.1074/jbc.M112.401521. Epub 2012 Nov 7.

8.

c-JUN prevents methylation of p16(INK4a) (and Cdk6): the villain turned bodyguard.

Kollmann K, Heller G, Sexl V.

Oncotarget. 2011 May;2(5):422-7.

9.

Transcriptional suppression of IL-27 production by Mycobacterium tuberculosis-activated p38 MAPK via inhibition of AP-1 binding.

Zhang J, Qian X, Ning H, Eickhoff CS, Hoft DF, Liu J.

J Immunol. 2011 May 15;186(10):5885-95. doi: 10.4049/jimmunol.1003447. Epub 2011 Apr 11.

10.

JunD and JunB integrate prostaglandin E2 activation of breast cancer-associated proximal aromatase promoters.

Chen D, Reierstad S, Fang F, Bulun SE.

Mol Endocrinol. 2011 May;25(5):767-75. doi: 10.1210/me.2010-0368. Epub 2011 Mar 10.

11.

c-Jun promotes whereas JunB inhibits epidermal neoplasia.

Jin JY, Ke H, Hall RP, Zhang JY.

J Invest Dermatol. 2011 May;131(5):1149-58. doi: 10.1038/jid.2011.1. Epub 2011 Feb 3. Erratum in: J Invest Dermatol. 2011 Jun;131(6):1388.

12.

Emerging roles of ATF2 and the dynamic AP1 network in cancer.

Lopez-Bergami P, Lau E, Ronai Z.

Nat Rev Cancer. 2010 Jan;10(1):65-76. doi: 10.1038/nrc2681. Review. Erratum in: Nat Rev Cancer. 2010 May;10(5):379.

13.

miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.

Garofalo M, Di Leva G, Romano G, Nuovo G, Suh SS, Ngankeu A, Taccioli C, Pichiorri F, Alder H, Secchiero P, Gasparini P, Gonelli A, Costinean S, Acunzo M, Condorelli G, Croce CM.

Cancer Cell. 2009 Dec 8;16(6):498-509. doi: 10.1016/j.ccr.2009.10.014.

14.

Downregulation of JUNB mRNA expression in advanced phase chronic myelogenous leukemia.

Hoshino K, Quintás-Cardama A, Radich J, Dai H, Yang H, Garcia-Manero G.

Leuk Res. 2009 Oct;33(10):1361-6. doi: 10.1016/j.leukres.2009.03.044. Epub 2009 May 5.

16.

Critical role for NF-kappaB-induced JunB in VEGF regulation and tumor angiogenesis.

Schmidt D, Textor B, Pein OT, Licht AH, Andrecht S, Sator-Schmitt M, Fusenig NE, Angel P, Schorpp-Kistner M.

EMBO J. 2007 Feb 7;26(3):710-9. Epub 2007 Jan 25.

17.

Mutual regulation of c-Jun and ATF2 by transcriptional activation and subcellular localization.

Liu H, Deng X, Shyu YJ, Li JJ, Taparowsky EJ, Hu CD.

EMBO J. 2006 Mar 8;25(5):1058-69. Epub 2006 Mar 2. Erratum in: EMBO J. 2006 Jun 21;25(12):2952.

18.

Evaluation of cancer-preventive activity and structure-activity relationships of 3-demethylubiquinone Q2, isolated from the ascidian Aplidium glabrum, and its synthetic analogs.

Fedorov SN, Radchenko OS, Shubina LK, Balaneva NN, Bode AM, Stonik VA, Dong Z.

Pharm Res. 2006 Jan;23(1):70-81. Epub 2006 Dec 5.

19.

Molecular determinants of NOTCH4 transcription in vascular endothelium.

Wu J, Iwata F, Grass JA, Osborne CS, Elnitski L, Fraser P, Ohneda O, Yamamoto M, Bresnick EH.

Mol Cell Biol. 2005 Feb;25(4):1458-74.

20.

Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects.

Kenner L, Hoebertz A, Beil FT, Keon N, Karreth F, Eferl R, Scheuch H, Szremska A, Amling M, Schorpp-Kistner M, Angel P, Wagner EF.

J Cell Biol. 2004 Feb 16;164(4):613-23. Epub 2004 Feb 9. Erratum in: J Cell Biol. 2011 Dec 12;195(6):1063. Beil, Timo [corrected to Beil, F Timo].

Supplemental Content

Support Center